Works matching DE "COMBINATION drug therapy"


Results: 5000
    1
    2
    3

    Comparative effectiveness of extended‐release naltrexone versus buprenorphine‐naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population‐based observational data

    Published in:
    Addiction, 2025, v. 120, n. 8, p. 1634, doi. 10.1111/add.70040
    By:
    • Lodi, Sara;
    • Yan, Shapei;
    • Bovell‐Ammon, Benjamin;
    • Christine, Paul J.;
    • Hsu, Heather E.;
    • Bernson, Dana;
    • Novo, Patricia;
    • Lee, Joshua D.;
    • Rotrosen, John;
    • Liebschutz, Jane M.;
    • Walley, Alexander Y.;
    • Larochelle, Marc R.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma.

    Published in:
    Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf138
    By:
    • Beckermann, Kathryn E;
    • Shah, Neil J;
    • Campbell, Matthew T;
    • Haas, Naomi B;
    • Nelson, Ariel;
    • Ornstein, Moshe C;
    • Mao, Shifeng;
    • Keshava-Prasad, Holavanahalli S;
    • Hammers, Hans;
    • Gao, Xin;
    • Gourdin, Theodore;
    • George, Saby;
    • Hoimes, Christopher J;
    • Hussain, Arif;
    • Jonasch, Eric;
    • Rini, Brian I;
    • Voss, Martin H
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    From Other Journals.

    Published in:
    Emergency Medicine Australasia, 2024, v. 36, n. 1, p. 170, doi. 10.1111/1742-6723.14362
    By:
    • Mallows, James;
    • Beck, Sierra;
    • Honan, Bridget;
    • Ting, Joseph
    Publication type:
    Article
    26
    27
    28

    From Other Journals.

    Published in:
    Emergency Medicine Australasia, 2018, v. 30, n. 1, p. 137, doi. 10.1111/1742-6723.12930
    By:
    • Furyk, Jeremy;
    • Banks, Colin
    Publication type:
    Article
    29

    From other journals.

    Published in:
    Emergency Medicine Australasia, 2017, v. 29, n. 2, p. 254, doi. 10.1111/1742-6723.12751
    By:
    • Furyk, Jeremy;
    • Banks, Colin
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    DIGEST.

    Published in:
    Diabetic Foot Journal, 2022, v. 25, n. 3, p. 48
    By:
    • Baker, Neil
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    New TB drug cocktail.

    Published in:
    Nature Reviews Microbiology, 2012, v. 10, n. 9, p. 594, doi. 10.1038/nrmicro2864
    By:
    • Kåhrström, Christina Tobin
    Publication type:
    Article
    46
    47
    48
    49
    50

    Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.

    Published in:
    Liver International, 2016, v. 36, n. 2, p. 189, doi. 10.1111/liv.12964
    By:
    • Everson, Gregory T.;
    • Sims, Karen D.;
    • Thuluvath, Paul J.;
    • Lawitz, Eric;
    • Hassanein, Tarek;
    • Rodriguez ‐ Torres, Maribel;
    • Desta, Tadesse;
    • Hawkins, Trevor;
    • Levin, James M.;
    • Hinestrosa, Federico;
    • Rustgi, Vinod;
    • Schwartz, Howard;
    • Younossi, Zobair;
    • Webster, Lynn;
    • Gitlin, Norman;
    • Eley, Timothy;
    • Huang, Shu ‐ Pang;
    • McPhee, Fiona;
    • Grasela, Dennis M.;
    • Gardiner, David F.
    Publication type:
    Article